Allogene Therapeutics Announces February and March 2019 Investor Conference Schedule
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering […]
SOUTH SAN FRANCISCO, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering […]
Entasis to incorporate BIOFIRE® FILMARRAY® System, a rapid molecular diagnostic platform, into ETX2514SUL Phase 3 clinical trial, on track to […]
Leadership and Track Record in Scaling Sustainable Fermentation-Based Commercial Products Leads to One of Largest Agreements to Date in Cannabinoid […]
Going Forward, We Will Be Silent Regarding Future Expectations for REMOXY AUSTIN, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) — Pain […]
According to new survey results, 81% of physicians believe virtual assistants in healthcare would reduce the burden on care teams […]
SAN DIEGO and LONDON, Feb. 05, 2019 (GLOBE NEWSWIRE) — Mitek (NASDAQ:MITK) and BioMetric Signature ID™ (BSI), a leading developer of […]
IRVING, Texas, Feb. 05, 2019 (GLOBE NEWSWIRE) — Blucora, Inc. (NASDAQ: BCOR), leading provider of tax-smart financial solutions that empower people’s […]
BASKING RIDGE, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage […]
Highlighting market adoption of VCSEL technology for 3D Sensing SUNNYVALE, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) — Finisar (NASDAQ: FNSR), […]
New Candidate Program and Community Forum launched, expanding FactSet’s alternative data ecosystem NORWALK, Conn., Feb. 05, 2019 (GLOBE NEWSWIRE) — […]